BX Swiss - USA
0,00
PKT
±0,00
PKT
±0,00
%
Werbung
Analysen zu BX Swiss - USA-Werten
Datum | Rating | Analyst | |
---|---|---|---|
15.09.17 | Vertex Pharmaceuticals Outperform | RBC Capital Markets | |
15.09.17 | Gilead Sciences Outperform | RBC Capital Markets | |
15.09.17 | Alexion Pharmaceuticals Outperform | RBC Capital Markets | |
15.09.17 | Morgan Stanley overweight | JP Morgan Chase & Co. | |
15.09.17 | Goldman Sachs overweight | JP Morgan Chase & Co. | |
15.09.17 | Oracle overweight | JP Morgan Chase & Co. | |
15.09.17 | Sirius XM Sector Perform | RBC Capital Markets | |
15.09.17 | Bayer buy | Commerzbank AG | |
15.09.17 | Bayer buy | equinet AG | |
15.09.17 | Morgan Stanley buy | HSBC | |
14.09.17 | Apple Buy | Maxim Group | |
14.09.17 | Bed Bath Beyond Neutral | UBS AG | |
14.09.17 | Apple Outperform | RBC Capital Markets | |
14.09.17 | Bayer buy | Warburg Research | |
13.09.17 | Alexion Pharmaceuticals Buy | Deutsche Bank AG | |
13.09.17 | Nike Buy | Deutsche Bank AG | |
13.09.17 | Apple Outperform | Bernstein Research | |
13.09.17 | Bayer Halten | Independent Research GmbH | |
13.09.17 | Apple Equal weight | Barclays Capital | |
13.09.17 | Apple overweight | JP Morgan Chase & Co. | |
13.09.17 | Bayer buy | Warburg Research | |
13.09.17 | Bayer overweight | JP Morgan Chase & Co. | |
13.09.17 | Apple buy | UBS AG | |
13.09.17 | Bayer buy | UBS AG | |
13.09.17 | Bayer Hold | Baader Bank | |
12.09.17 | Oracle Outperform | RBC Capital Markets | |
11.09.17 | Apple overweight | JP Morgan Chase & Co. | |
11.09.17 | Apple Outperform | RBC Capital Markets | |
07.09.17 | Intel Halten | Independent Research GmbH | |
07.09.17 | Amazon Buy | D.A. Davidson & Co. | |
06.09.17 | Caterpillar Buy | Seaport Global Securities | |
06.09.17 | Apple buy | Nomura | |
06.09.17 | Chevron Neutral | UBS AG | |
06.09.17 | ExxonMobil Neutral | UBS AG | |
06.09.17 | Bayer Neutral | BNP PARIBAS | |
05.09.17 | C.H. Robinson Worldwide Neutral | UBS AG | |
05.09.17 | Bayer Outperform | Bernstein Research | |
01.09.17 | Apple Outperform | RBC Capital Markets | |
31.08.17 | Baker Hughes overweight | Barclays Capital | |
31.08.17 | Analog Devices Outperform | RBC Capital Markets |